We are live on ! Find out more
ENTA icon

Enanta Pharmaceuticals
ENTA

176 hedge funds and large institutions have $1.08B invested in Enanta Pharmaceuticals in 2019 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 81 increasing their positions, 54 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 81 | Existing positions reduced: 54

1.19% more ownership

Funds ownership: 89.73% → 90.92% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

9% less funds holding

Funds holding: 194 → 176 (-18)

28% less call options, than puts

Call options by funds: $5.22M | Put options by funds: $7.2M

28% less capital invested

Capital invested by funds: $1.49B → $1.08B (-$414M)

58% less first-time investments, than exits

New positions opened: 13 | Existing positions closed: 31

Holders
176
Holders Change
-18
Holders Change %
-9.28%
% of All Funds
3.86%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
13
Increased
81
Reduced
54
Closed
31
Calls
$5.22M
Puts
$7.2M
Net Calls
-$1.99M
Net Calls Change
+$5.67M

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$23.3M
2
AC
Armistice Capital
New York
+$14.9M
3
Man Group
Man Group
United Kingdom
+$14.2M
4
Renaissance Technologies
Renaissance Technologies
New York
+$8.36M
5
Goldman Sachs
Goldman Sachs
New York
+$7.19M

Top Sellers

Rank Fund Capital Flow
1
Ameriprise
Ameriprise
Minnesota
-$34.9M
2
Citadel Advisors
Citadel Advisors
Florida
-$13M
3
First Manhattan
First Manhattan
New York
-$8.11M
4
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$5.9M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
ARTA
76
A.R.T. Advisors
New York
$1.03M +$1.27M +17,147 New
SG Americas Securities
77
SG Americas Securities
New York
$1.02M +$1.17M +15,697 +1,181%
PI
78
PineBridge Investments
New York
$920K +$94.9K +1,277 +9%
Comerica Bank
79
Comerica Bank
Texas
$895K +$7.95K +107 +0.7%
Ohio Public Employees Retirement System (OPERS)
80
Ohio Public Employees Retirement System (OPERS)
Ohio
$816K – – –
KC
81
Kepos Capital
New York
$791K -$508K -6,832 -34%
KBC Group
82
KBC Group
Belgium
$772K -$676K -9,104 -41%
AIG
83
American International Group
New York
$756K -$10.2K -137 -1%
SOADOR
84
State of Alaska Department of Revenue
Alaska
$735K +$507K +6,827 +126%
Fisher Asset Management
85
Fisher Asset Management
Washington
$726K – – –
Voloridge Investment Management
86
Voloridge Investment Management
Florida
$719K +$889K +11,968 New
SO
87
STRS Ohio
Ohio
$708K +$59.4K +800 +7%
State of Tennessee, Department of Treasury
88
State of Tennessee, Department of Treasury
Tennessee
$708K +$75K +1,009 +9%
Bank of America
89
Bank of America
North Carolina
$704K -$2.24M -30,089 -72%
VOYA Investment Management
90
VOYA Investment Management
Georgia
$704K -$2.97K -40 -0.3%
UBS AM
91
UBS AM
Illinois
$698K -$103K -1,385 -11%
D.E. Shaw & Co
92
D.E. Shaw & Co
New York
$679K +$640K +8,614 +321%
TPSF
93
Texas Permanent School Fund
Texas
$652K +$2.82K +38 +0.4%
Manulife (Manufacturers Life Insurance)
94
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$646K -$7.13K -96 -0.9%
VRS
95
Virginia Retirement Systems
Virginia
$637K +$52K +700 +7%
CM
96
Caption Management
Oklahoma
$600K – – –
State Board of Administration of Florida Retirement System
97
State Board of Administration of Florida Retirement System
Florida
$562K – – –
First Trust Advisors
98
First Trust Advisors
Illinois
$529K -$2.44M -32,838 -79%
SDIC
99
South Dakota Investment Council
South Dakota
$529K +$594K +8,000 +1,000%
Federated Hermes
100
Federated Hermes
Pennsylvania
$497K +$2.75K +37 +0.4%
2 3
4
5 6

ENTA Hedge Fund Activity: Q3 2019 in Review

176 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Enanta Pharmaceuticals (ENTA) for Q3 2019, worth a combined $1.08B — down 28% from $1.49B a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of ENTA and 13 opened new positions — a net loss of 18 holders — while 54 trimmed existing stakes and 81 added.

The largest buyer was Farallon Capital Management, adding an estimated $23.3M. The largest seller was Ameriprise, cutting an estimated $34.9M.

  • 176 institutional investors held Enanta Pharmaceuticals (ENTA) as of Q3 2019, down from 194 in Q2 2019.
  • Funds reported $1.08B of Enanta Pharmaceuticals stock for Q3 2019, down 28% quarter-over-quarter.
  • 13 funds opened new Enanta Pharmaceuticals positions in Q3 2019 and 31 closed out, a net change of -18 holders.
  • The largest Enanta Pharmaceuticals buyer in Q3 2019 was Farallon Capital Management, an estimated $23.3M added.
  • The largest Enanta Pharmaceuticals seller in Q3 2019 was Ameriprise, an estimated $34.9M sold.

Based on aggregated 13F filings for Q3 2019.